SCHEMBL21546947

SCHEMBL21546947

Cc1ccc(-c2ccc3c(c2)c2ccccc2n3-c2cc(C#N)cc(-n3c4ccccc4c4cc(-c5ccc(C)cc5C)ccc43)c2-c2cccc(C#N)c2)c(C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.36
PTGER4 P35408 1/20 0.35
CYP1A2 P05177 5/20 0.33
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 2/20 0.33
CYP2C9 P11712 2/20 0.33
TSHR P16473 2/20 0.33
MAPK1 P28482 2/20 0.33
HSD17B10 Q99714 2/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PRF1 P14222 1/20 0.33
BRD4 O60885 1/20 0.33
CHEK1 O14757 1/20 0.33
ADRA2C P18825 1/20 0.33
PDE9A O76083 1/20 0.32
PDE1C Q14123 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21546982 0.96 ELANE (0.36) ELANECYP1A2ALDH1A1KDM4ELMNA
SCHEMBL21546480 0.95 ELANE (0.35) ELANEPTGER4CYP1A2ALDH1A1KDM4E
SCHEMBL21414141 0.94 PDE9A (0.35) PTGER4ALDH1A1KDM4ELMNAHSD17B10
SCHEMBL21928373 0.91 CYP1A2 (0.36) ELANEPTGER4CYP1A2ALDH1A1KDM4E
SCHEMBL21546985 0.91 ELANE (0.35) ELANECYP1A2ALDH1A1KDM4ELMNA
SCHEMBL21546705 0.91 ADRA2C (0.37) ELANEPTGER4CYP1A2ALDH1A1LMNA
SCHEMBL21546916 0.91 MAT2A (0.36) ELANEPTGER4PRF1ARPDK2
SCHEMBL21546948 0.89 PTGER4 (0.37) ELANEPTGER4CYP1A2ALDH1A1KDM4E
SCHEMBL21546728 0.88 ALDH1A1 (0.39) ELANEPTGER4CYP1A2ALDH1A1KDM4E
SCHEMBL21414252 0.88 ALDH1A1 (0.32) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10981930-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2021-04-20 US disclosed
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-10 US disclosed
EP-3478793-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-11-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10981930-B2 Organic molecules for use in optoelectronic devices OR10J3, OR51E2, EPCAM ELANE 2057/4885PTGER4 1356/4885CYP1A2 512/4885
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OR51E2, EPCAM ELANE 2057/4885PTGER4 1356/4885CYP1A2 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.